Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:MNTR OTCMKTS:PKPH OTCMKTS:PVSP NASDAQ:XXII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMNTRMentor Capital$0.04$0.04$0.03▼$0.14$810K-0.813,921 shs2,300 shsPKPHPeak Pharmaceuticals$1.00$0.98$0.52▼$9.12$392K0.549,053 shs1 shsPVSPPervasip$0.00$0.00$0.00▼$0.00$1.09M-0.67522,004 shs240,000 shsXXII22nd Century Group$4.01$12.69$3.74▼$2,841.00$893K0.6742,358 shs22,506 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMNTRMentor Capital0.00%+1.91%-22.77%-33.39%-27.57%PKPHPeak Pharmaceuticals0.00%+15.03%+15.03%+8.37%-7.41%PVSPPervasip0.00%0.00%+100.00%0.00%0.00%XXII22nd Century Group0.00%+2.04%-61.37%-91.17%-99.81%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMNTRMentor Capital$0.04$0.04$0.03▼$0.14$810K-0.813,921 shs2,300 shsPKPHPeak Pharmaceuticals$1.00$0.98$0.52▼$9.12$392K0.549,053 shs1 shsPVSPPervasip$0.00$0.00$0.00▼$0.00$1.09M-0.67522,004 shs240,000 shsXXII22nd Century Group$4.01$12.69$3.74▼$2,841.00$893K0.6742,358 shs22,506 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMNTRMentor Capital0.00%+1.91%-22.77%-33.39%-27.57%PKPHPeak Pharmaceuticals0.00%+15.03%+15.03%+8.37%-7.41%PVSPPervasip0.00%0.00%+100.00%0.00%0.00%XXII22nd Century Group0.00%+2.04%-61.37%-91.17%-99.81%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMNTRMentor Capital 0.00N/AN/AN/APKPHPeak Pharmaceuticals 0.00N/AN/AN/APVSPPervasip 0.00N/AN/AN/AXXII22nd Century Group 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest PKPH, PVSP, XXII, and MNTR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/18/2026XXII22nd Century Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)6/4/2026XXII22nd Century Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)5/22/2026XXII22nd Century Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)5/7/2026XXII22nd Century Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)(Data available from 7/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMNTRMentor Capital$170K4.76N/AN/A$0.11 per share0.34PKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/APVSPPervasip$15.77M0.07N/AN/AN/A∞XXII22nd Century Group$6.06M0.15N/AN/A$617.74 per share0.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMNTRMentor Capital-$570K-$0.03N/AN/AN/A-261.84%-23.05%-18.62%N/APKPHPeak Pharmaceuticals-$160KN/AN/AN/AN/AN/AN/A-159.55%N/APVSPPervasip-$140KN/AN/AN/AN/AN/AN/A-32,601.27%N/AXXII22nd Century Group-$5.05M-$4,365.26N/AN/AN/A-25.34%-84.37%-45.90%8/19/2026 (Estimated)Latest PKPH, PVSP, XXII, and MNTR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026MNTRMentor CapitalN/A-$0.01N/A-$0.01N/A$0.04 million5/7/2026Q1 2026XXII22nd Century Group-$24.00-$5.07+$18.93-$361.60$4.61 million$4.11 million4/15/2026Q4 2025MNTRMentor CapitalN/A-$0.01N/A-$0.01N/A$0.05 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthMNTRMentor CapitalN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/APVSPPervasipN/AN/AN/AN/AN/AXXII22nd Century GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMNTRMentor CapitalN/A13.3813.38PKPHPeak PharmaceuticalsN/A0.150.15PVSPPervasipN/AN/AN/AXXII22nd Century Group0.022.672.12Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMNTRMentor CapitalN/APKPHPeak PharmaceuticalsN/APVSPPervasipN/AXXII22nd Century Group18.06%Insider OwnershipCompanyInsider OwnershipMNTRMentor Capital23.73%PKPHPeak Pharmaceuticals18.40%PVSPPervasip9.20%XXII22nd Century Group0.01%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMNTRMentor Capital221.68 million16.54 millionNot OptionablePKPHPeak Pharmaceuticals1392,000320,000Not OptionablePVSPPervasip35.43 billion4.93 billionNot OptionableXXII22nd Century Group80223,000516,000No DataPKPH, PVSP, XXII, and MNTR HeadlinesRecent News About These Companies22nd Century faces contract termination, seeks new manufacturing opportunitiesJuly 2 at 6:11 PM | tipranks.com22nd Century Group (NASDAQ:XXII) Upgraded by Wall Street Zen to Sell RatingJune 27, 2026 | americanbankingnews.com22nd Century Shareholders Back Board, Pay and Auditor PlansJune 11, 2026 | tipranks.com22nd Century Group (Nasdaq: XXII) Launches Pinnacle VLN® Trial in California, Opening Another Major New State for Reduced-Nicotine CigarettesMay 21, 2026 | globenewswire.com22nd Century Group (Nasdaq: XXII) Expands High-Margin Pinnacle Platform With Launch of Pinnacle Pure at Major U.S. RetailersMay 18, 2026 | globenewswire.com22nd Century Group Expands Distribution of VLN® Cigarettes to 150 New Locations in Metro New York and Northern New JerseyMay 15, 2026 | quiverquant.comQ22nd Century Group (Nasdaq: XXII) Ignites Major VLN® Retail Expansion in Metro New York and Northern New Jersey Under Pinnacle BrandMay 15, 2026 | globenewswire.com22nd Century Group, Inc. (NASDAQ:XXII) Q1 2026 Earnings Call TranscriptMay 13, 2026 | insidermonkey.com22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific ReviewMay 12, 2026 | globenewswire.com22nd Century Group, Inc. (XXII) Q1 2026 Earnings Call Prepared Remarks TranscriptMay 9, 2026 | seekingalpha.com22nd Century Group Reports First Quarter 2026 Financial ResultsMay 7, 2026 | globenewswire.com22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026May 4, 2026 | globenewswire.com22nd Century Files Prospectus for Potential ATM Stock OfferingMay 1, 2026 | tipranks.com22nd Century Group (XXII) slides 12.6% as rally fades and dilution risk stays in focusMay 1, 2026 | quiverquant.comQ22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction LeadershipApril 29, 2026 | globenewswire.com22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State UniversityApril 23, 2026 | globenewswire.com22nd Century Group, Inc.April 9, 2026 | edition.cnn.com22nd Century Group's reduced nicotine bet falls flat with investorsApril 7, 2026 | msn.com22nd Century Group's reduced nicotine bet falls falls flat with investorsApril 7, 2026 | seekingalpha.com22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product InitiativeApril 7, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePKPH, PVSP, XXII, and MNTR Company DescriptionsMentor Capital OTCMKTS:MNTR$0.04 0.00 (0.00%) As of 07/2/2026 10:37 AM EasternMentor Capital, Inc. is a private equity firm specializing in acquisitions and emerging growth investments. The firm provides passive equity funding and liquidity to smaller companies and owners in the medical, marijuana and social use cannabis companies. It invests in shelf IPO's and public and private companies and seeks to provide public market access to owners of small private companies. The firm specializes in pre-IPO investments in Cannabis companies. It seeks to invest in energy sector of oil and gas, coal, uranium. In case of shelf IPO's, the firm prefers to invest in companies with sales greater than $40 million. It prefers to take significant position in its portfolio companies. The firm invests only in companies that have earnings. Mentor Capital, Inc. was founded in 1985 and is based in Plano, Texas.Peak Pharmaceuticals OTCMKTS:PKPH$1.00 0.00 (0.00%) As of 07/2/2026Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.Pervasip OTCMKTS:PVSP$0.0002 0.00 (0.00%) As of 07/2/2026 12:56 PM EasternPervasip Corporation focuses on developing cloud-based applications to monitor and control greenhouse facilities. It intends to develop and deliver products and technologies to agricultural markets; develop scientific methods for the analysis of cannabinoids in flowers, concentrates, and edibles; and assist medical marijuana specialty production facilities to regulate, calculate proper dosage, and understand the importance of consistency in product. The company was formerly known as eLEC Communications Corp. and changed its name to Pervasip Corp. in December 2007. Pervasip Corp. was founded in 1964 and is based in White Plains, New York.22nd Century Group NASDAQ:XXII$4.01 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$4.07 +0.06 (+1.40%) As of 07/2/2026 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/29 - 07/03 Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst This Under-the-Radar Industrial Is Quietly Powering AI SanDisk’s Volatility May Be Telling Bulls What They Want to Hear Broadcom and OpenAI Unveil Jalapeño: An Early Step to Massive AI Growth Potential Why the Comcast Spin-Off Won't Fix What's Actually Broken Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
